Skip to main content
Pharmaco Vigilance
Search form
Search
Home
Perspectives
Case Reports
Focus on
Columns
News
Links
About us
Contacts
News
February 2022
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies
February 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
January 2022
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
January 2022
Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination
January 2022
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
December 2021
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine
December 2021
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
December 2021
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
November 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
November 2021
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
80.211.154.110
